These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2804254)

  • 1. Absorption kinetics of topical clindamycin preparations.
    Eller MG; Smith RB; Phillips JP
    Biopharm Drug Dispos; 1989; 10(5):505-12. PubMed ID: 2804254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
    Goltz RW; Coryell GM; Schnieders JR; Neidert GL
    Cutis; 1985 Sep; 36(3):265-8. PubMed ID: 2932307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
    Stoughton RB; Cornell RC; Gange RW; Walter JF
    Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream.
    Borin MT; Powley GW; Tackwell KR; Batts DH
    J Antimicrob Chemother; 1995 Jun; 35(6):833-41. PubMed ID: 7559194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
    Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
    Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic absorption of clindamycin after intravaginal administration of clindamycin phosphate ovule or cream.
    Borin MT; Ryan KK; Hopkins NK
    J Clin Pharmacol; 1999 Aug; 39(8):805-10. PubMed ID: 10434232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations.
    Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL
    Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic absorption of clindamycin hydrochloride after topical application.
    Barza M; Goldstein JA; Kane A; Feingold DS; Pochi PE
    J Am Acad Dermatol; 1982 Aug; 7(2):208-14. PubMed ID: 6215432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.
    Gatti G; Flaherty J; Bubp J; White J; Borin M; Gambertoglio J
    Antimicrob Agents Chemother; 1993 May; 37(5):1137-43. PubMed ID: 8517703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the bioavailability of topical formulations of clindamycin hydrochloride.
    Franz TJ
    J Am Acad Dermatol; 1983 Jul; 9(1):66-73. PubMed ID: 6886106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical clindamycin in acne vulgaris. Safety and stability.
    Algra RJ; Rosen T; Waisman M
    Arch Dermatol; 1977 Oct; 113(10):1390-1. PubMed ID: 143910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.
    Swinyer LJ; Baker MD; Swinyer TA; Mills OH
    Br J Dermatol; 1988 Nov; 119(5):615-22. PubMed ID: 2974719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
    Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
    J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal concentration and excretion of clindamycin by the human stomach.
    Hextall A; Radley S; Andrews JM; Boyd EJ; Dent JC; Donovan I; Wise R
    J Antimicrob Chemother; 1994 Mar; 33(3):595-602. PubMed ID: 8040123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.
    Mazur D; Schug BS; Evers G; Larsimont V; Fieger-Büschges H; Gimbel W; Keilbach-Bermann A; Blume HH
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):386-92. PubMed ID: 10475141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical clindamycin in the management of acne vulgaris.
    Guay DR
    Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topically administered clindamycin in the treatment of acne vulgaris and other dermatologic disorders.
    Rosen T; Waisman M
    Pharmacotherapy; 1981; 1(3):201-5. PubMed ID: 6242711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.